Novel, thalidomide-like, non-cereblon binding drug tetrafluorobornylphthalimide mitigates inflammation and brain injury.

J Biomed Sci · 2023 · PMC9987061 · PMID 36872339

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

did not reach statistical significanceno p-value reported

A decreasing trend was noticeable in the TFBP treated groups in relation to this measure, but did not reach statistical significance (Fig. 6 A, B).

also in 47,180 other papers

failed to reach statistical significanceno p-value reported

A trend to decline was evident in the higher TFBP dose group that failed to reach statistical significance.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.